Marcus Capital’s AbbVie ABBV Stock Holding History

Marcus Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$740K	Buy	7,825 +500	+7%	+$47.4K	2.16%	21
2018 Q2	$679K	Buy	7,325 +1,650	+29%	+$161K	2.16%	22
2018 Q1	$537K	Sell	5,675 -950	-14%	-$104K	1.98%	23
2017 Q4	$641K	Sell	6,625 -10,125	-60%	-$954K	2.45%	18
2017 Q3	$1.49M	Sell	16,750 -10,000	-37%	-$761K	2.11%	23
2017 Q2	$1.94M	Sell	26,750 -150	-0.6%	-$10.1K	1.66%	29
2017 Q1	$1.75M	Sell	26,900 -100	-0.4%	-$6.29K	1.64%	29
2016 Q4	$1.69M	Sell	27,000 -100	-0.4%	-$6.1K	1.82%	27
2016 Q3	$1.71M	Hold	27,100	–	–	1.64%	30
2016 Q2	$1.68M	Sell	27,100 -50	-0.2%	-$3.05K	1.77%	28
2016 Q1	$1.55M	Hold	27,150	–	–	1.71%	27
2015 Q4	$1.61M	Buy	+27,150	New	+$1.56M	1.71%	28

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marcus Capital's ABBV Position: Q3 2018 in Review

Marcus Capital increased its AbbVie (ABBV) stake by 6.8% in Q3 2018, buying an estimated $47.4K and bringing the position to 7,825 shares worth $740K. The position accounts for 2.16% of the portfolio, ranked #21.

Marcus Capital first reported a position in ABBV in Q4 2015 and has held it in 12 quarters since. The position peaked at $1.94M in Q2 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Marcus Capital held 7,825 shares of AbbVie worth $740K as of Q3 2018.
Marcus Capital bought 500 AbbVie shares in Q3 2018, an estimated $47.4K.
AbbVie made up 2.16% of Marcus Capital's portfolio in Q3 2018, its #21 holding.
Marcus Capital first reported a position in AbbVie in Q4 2015 and has held it in 12 quarters since.
Marcus Capital's AbbVie position peaked at $1.94M in Q2 2017.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Marcus Capital's 13F filing for Q3 2018, filed 13 Nov 2018.